Founded in 2013, Clevergene operates in Health Tech industry. Initially focusing on providing detailed genomic analysis services, the company has evolved to offer a comprehensive range of next-generat...
Funding stage:
Seed
Last funding:
11/02/2020
Total funding:
$631.00K+
Revenue:
Investors
Employee count:
15
Last 90d
15
Last 90d
Web traffic:
1.1K
1.1K
Last 30d
Last 30d
Glassdoor Rating:
Clevergene: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders6
Latest Filing Date29 Sept 2022- Funding Events13
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Clevergene
As of 30 September 2022, Clevergene's equity is held by 6 shareholders, with the top three being Tony Jose, Auxano, and Somaprasad MP.
Tony Jose holds the largest stake in Clevergene at 48.1% as of 30 September 2022.
As of 30 September 2022, founders collectively hold 58.1% equity in Clevergene.
As of 30 September 2022, investors collectively hold 17.4% equity in Clevergene.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links